Stem Cell Therapeutics Completes Patient Assesment for Modified Regenesis Phase IIb Stroke Trial
The modified Regenesis Phase IIb trial is a placebo controlled, double blinded, 3:1 randomised clinical study, enrolled 96 patients with acute ischemic stroke between August 2009 and January
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.